Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000167025 | SCV000217848 | likely benign | Hereditary cancer-predisposing syndrome | 2014-11-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000204553 | SCV000259821 | likely benign | Neurofibromatosis, type 1 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000781664 | SCV000919879 | likely benign | not specified | 2024-12-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001589041 | SCV001827101 | likely benign | not provided | 2021-08-18 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000781664 | SCV002069597 | uncertain significance | not specified | 2019-08-23 | criteria provided, single submitter | clinical testing |